37
Views
8
CrossRef citations to date
0
Altmetric
Research Article

The Effect of Atorvastatin on Serum Lipids, Lipoprotein(a) and Plasma Fibrinogen Levels in Primary Dyslipidaemia – A Pilot Study Involving Serial Sampling

, , , , &
Pages 269-275 | Published online: 01 Jan 2000

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Evagelos N. Liberopoulos, Stella S. Daskalopoulou, Dimitri P. Mikhailidis, Anthony S. Wierzbicki & Moses S. Elisaf. (2005) A review of the lipid-related effects of fluvastatin. Current Medical Research and Opinion 21:2, pages 231-243.
Read now
Dimitri P. Mikhailidis & Anthony S. Wierzbicki. (2002) The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Current Medical Research and Opinion 18:4, pages 215-219.
Read now
Anthony S. Wierzbicki. (2001) Synthetic Statins: More Data on Newer Lipid-lowering Agents. Current Medical Research and Opinion 17:1, pages 74-77.
Read now

Articles from other publishers (5)

Amirhossein Sahebkar, Maria-Corina Serban, Dimitri P. Mikhailidis, Peter P. Toth, Paul Muntner, Sorin Ursoniu, Svetlana Mosterou, Stephen Glasser, Seth S. Martin, Steven R. Jones, Manfredi Rizzo, Jacek Rysz, Allan D. Sniderman, Michael J. Pencina & Maciej Banach. (2016) Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. Pharmacological Research 103, pages 236-252.
Crossref
Stephen P Adams, Michael Tsang & James M Wright. (2015) Atorvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Stephen P Adams, Michael Tsang & James M Wright. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Moses Elisaf & Dimitri P. Mikhailidis. (2016) Statins and Renal Function. Angiology 53:5, pages 493-502.
Crossref
Evagelos Rizos, Angeliki Kostoula, Moses Elisaf & Dimitri P. Mikhailidis. (2016) Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen Levels. Angiology 53:3, pages 273-277.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.